Emulate's Series B - II Round

Emulate raised a round of funding on October 20, 2016.

Emulate is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses t…

Articles about Emulate's Series B - II Round: